Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
Clinical trial NCT06068985 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06068985
- Sponsor
- Latin American Cooperative Oncology Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-05
- Primary completion
- 2026-04-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.